IgM-Mediated Receptor Clustering via Linker Mediator
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective means to modulate cellular functions specifically and efficiently, particularly for dendritic cells, using multivalent molecules like IgM antibodies, which require high affinity binding to endogenous ligands and specific cell surface receptors.
Innovation Solution
The use of linker molecules that include an epitope recognized by the multivalent molecule and a marker on the cell surface, allowing the IgM antibodies to cluster and cap cell surface molecules, initiating intracellular signaling and modulating cell functions, even with low affinity binding.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If IgM antibodies are used to bind endogenous ligands on cell surfaces, then cellular functions can be modulated, but high affinity binding is required which limits the scope of applicable targets
Solution Approach 1:
The patent introduces a linker molecule as an intermediary that connects the IgM antibody to the cell surface marker. The linker has two binding sites: one that binds to the IgM antibody (which has low affinity for endogenous ligands) and another that binds to a marker on the cell surface. This intermediary approach allows the IgM antibody to be targeted to specific cells without requiring high affinity binding to endogenous ligands, thereby resolving the contradiction between binding reliability and target versatility.
2Productivity
If multivalent molecules are used to cross-link cell surface targets, then biological potential is enhanced, but specific and efficient modulation of cellular functions is difficult to achieve
Solution Approach 1:
The patent applies local quality by directing the multivalent IgM molecule to a specific location on the cell surface through the linker molecule. The linker ensures that the IgM antibody is positioned at a specific site defined by the cell surface marker, allowing for localized cross-linking and modulation of cellular functions. This resolves the contradiction by enabling both the biological potential of multivalent cross-linking and the efficiency of specific modulation.
3Adaptability or versatility
If IgM antibodies with low affinity binding are used, then broader target selection is possible, but effective receptor clustering and cell modulation require high affinity interactions
Solution Approach 1:
The linker molecule serves as a mediator that bridges the gap between low affinity IgM binding and effective receptor clustering. The linker's cell surface marker binding provides stable anchoring, while the IgM antibody portion maintains its low affinity binding characteristics, allowing broad target selection. The linker translates the low affinity interaction into effective receptor clustering by providing a stable platform for multivalent cross-linking.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables targeted activation of dendritic cells and other cell types, facilitating immune responses, antigen uptake, and therapeutic applications such as treating allergic asthma and multiple sclerosis by forming multi-molecular caps and recruiting signaling molecules.
Implementation Method 1
a multivalent molecule specifically binds to an epitope present on the linker molecule
Implementation Method 2
its low affinity interaction with other endogenous ligands can result in receptor and cell surface molecule clustering, initiating intracellular signaling
Data Source
AI summary
Materials and methods for using multivalent molecules (e.g., antibodies) to modulate cellular function. A molecule can be targeted to a particular type of cell, either through direct binding to an epitope on the surface of the cell, or through a linker that recognizes both the multivalent molecule and a marker on the cell surface.